Issue 24, 2025

Differentiation of cisplatin uptake within a population of cancer cells – how to “crack this nut” using single-cell ICP-MS

Abstract

A versatile tool to unravel the uptake diversity of a front-line anticancer drug, cisplatin, within a cancer cell population is proposed herein based on single-cell inductively coupled plasma mass spectrometry. The interested researcher is provided with a tutorial to help adapt such cutting-edge methodology and know-how to reliable data processing.

Graphical abstract: Differentiation of cisplatin uptake within a population of cancer cells – how to “crack this nut” using single-cell ICP-MS

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Communication
Submitted
10 Feb 2025
Accepted
26 Aug 2025
First published
02 Sep 2025
This article is Open Access
Creative Commons BY license

Analyst, 2025,150, 5374-5378

Differentiation of cisplatin uptake within a population of cancer cells – how to “crack this nut” using single-cell ICP-MS

Z. Szymańska, M. Matczuk, A. Żuchowska, P. Romańczuk, A. R. Timerbaev and M. Jarosz, Analyst, 2025, 150, 5374 DOI: 10.1039/D5AN00152H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements